Trial
NCT00148720
Capecitabine in Women With Operable Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
Hoffmann-La Roche; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital
Condition
Invasive Breast Carcinoma
Intervention
Capecitabine
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-11-11